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ABSTRACT
Much of the knowledge regarding the regulatory pathways for adult stem cell self-renewal and dif-
ferentiation has been obtained from the results of in vitro cultures. However, it is unclear if adult
stem cells are controlled in the same way under physiological conditions. We examined this issue
with respect to the migration of stem cells to tissue injury and how switch from a migratory state
to one of proliferation wherein they participate in development. Building on our previous identifi-
cation of multipotent stem cells in trabecular bone, we have examined the in vitro behavior of these
cells within the bone milieu. We found that cell proliferation is inhibited within the trabecular bone
niche as cells migrate out of the trabecular bone prior to proliferation. Additionally, multiple cell
types were detected in adult trabecular bone, including osteoblasts, osteoclasts, endothelial cells, and
Stro-1-positive mesenchymal stem cells. Furthermore, we demonstrated that Stro-1-positive cells mi-
grated out of their native bone niche to generate multipotential stem and progenitor cells during in
vitro culture. We conclude that self-renewal and differentiation of adult stem cells in connective tis-
sues are tightly controlled and separately orchestrated processes. A regulatory network of extrinsic
factors and intrinsic signals acts to stimulate the exit of stem cells from their niche so that they can
localize to sites of wound healing, where they participate in development after functional differen-
tiation.
INTRODUCTION
MULTIPOTENTIAL STEM CELLS have been isolated fromnumerous postnatal tissues and organs such as bone
marrow, epithelia, skeletal muscle, and trabecular bone
(1–7). These cells are capable of extensive self-renewal
and multilineage differentiation during in vitro culturing.
At present, much of the knowledge regarding the regu-
lation of the maintenance, proliferation, and differentia-
tion of adult stem cells has been obtained from studies
using in vitro-expanded cells. Although in vitro cell cul-
ture systems provide invaluable insight into the nature of
adult stem cells, it is largely unknown if stem cells are
controlled in the same way in their native tissues and or-
gans in vivo.
In tissues and organs that undergo high turnover, such
as the hematopoietic system, the skin, and the intestine,
adult stem cells proliferate to maintain the stem cell reser-
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voir as well as to generate progenitor cells, which in turn
give rise to various differentiated cells during normal ho-
meostasis as well as during tissue regeneration and re-
pair upon damage. Adult stem cells are localized in a de-
fined in vivo microenvironment, i.e., niche (8), that
provides regulatory signals for cell proliferation and dif-
ferentiation. For example, the long-term hematopoietic
stem cells (HSCs) in murine bone marrow are located on
the endosteal surface of long bone, a niche consisting of
cavity-lining osteoblasts (9,10). Epithelial stem cells re-
side in the hair follicle bulge in the skin (2,11–13) and
at the base of the crypt in the intestine (14). Although tis-
sue-specific stem cells reside in a quite distinct mi-
croenvironment, they share a common characteristic by
remaining in a mitotically quiescent state inside the niche,
and only start to undergo asymmetric division upon ex-
iting their niche (13,14). Growth factors, extracellular
matrix (ECM) molecules, and proteins that mediate the
direct cell–cell interactions have been implicated to play
key roles in the process.
In addition to HSCs and epithelial stem cells, adult
stem cells can be isolated from several connective tis-
sues, such as the mesenchymal stem cells (MSCs) de-
rived from bone marrow (15), umbilical cord blood
(16,17), adipose tissues (18,19), and trabecular bone
(4,6), and muscle stem cells from skeletal muscle (3). Un-
like HSCs of the bone marrow and epithelial stem cells,
the in vivo functions of the stem cells that reside in con-
nective tissues that have a low remodeling rate are not
completely clear. For example, do they possess the same
regenerative function as HSCs, or are they merely the re-
sidual cells left from embryonic development? Such
questions can only be answered fully after the anatomi-
cal location and identity of these stem cells are identi-
fied. However, a number of challenges exist. MSCs and
muscle stem cells are isolated on the basis of their pref-
erence to adhere to tissue culture plastic (3,15) and are
defined largely by their capability to proliferate and dif-
ferentiate subsequently into cells of multiple lineages in
vitro. The lack of definitive cell-surface markers and rel-
atively low cell numbers also hinder the attempt to lo-
calize these stem cells in vivo.
Adult human trabecular bone, cultured as explants of
dissociated bone chips, has shown promising potential as
an alternative source for multipotential MSCs and pro-
genitor cells (4–6,20). We propose that trabecular bone
provides an in vivo niche for MSCs, and can be used as
an experimental model to study the maintenance and pro-
liferation of connective tissue-derived stem cells. In the
present study, we have examined adult human trabecular
bone to determine the origin of stem cells, identify their
location within the tissue, and to characterize their mi-
gration out of their microenvironment. We found that
multiple cell types, including a rare Stro-1-positive stem
cell population, exist in adult trabecular bone in situ and
exhibit the ability to differentiate subsequently into sev-
eral cell types of mesenchymal lineage. We also demon-
strate that cells located in the trabecular bone niche are
mitotically quiescent, and that cells migrate out of the
niche prior to division and subsequent differentiation.
Additionally, we demonstrate that outgrowth of trabecu-
lar bone cells is independent of cell proliferation.
MATERIALS AND METHODS
Reagents
Cell culture media and reagents were purchased from
Invitrogen (Carlsbad, CA). All chemicals were obtained
from Sigma-Aldrich (St. Louis, MO) unless specified
otherwise.
Isolation and culture of trabecular bone and
trabecular bone derived cells
Trabecular bone chips were obtained as described pre-
viously (4,5,7) from the femoral heads of patients (3 fe-
males, aged 54, 63, and 74; 1 male, 70 years) undergoing
total hip arthroplasty with Institutional Review Board ap-
proval from George Washington University. The bone
chips were digested with 0.2 mg/ml collagenase XI at 37°C
for 3 h followed by extensive rinsing with phosphate-
buffered saline (PBS) to remove adventitious tissues and
cells. The freshly isolated bone chips were divided into two
fractions. One part was fixed immediately with 4% para-
formaldehyde in PBS (FD NeuroTechnologies, Inc, Balti-
more, MD) for histological analysis. The other part was
cultured in basal medium (BM) containing Dulbecco’s
modified Eagle medium (DMEM), 10% fetal bovine serum
(FBS), 10 units/ml penicillin G sodium, 10 g/ml strepto-
mycin sulfate, and 0.25 g/ml Fungizone in a 37°C incu-
bator with 5% CO2. For some experiments, aphidicolin, a
cell cycle inhibitor, was added to the trabecular bone cul-
ture at a final concentration of 1 g/ml to block cell pro-
liferation. Human MSCs were also isolated from bone mar-
row aspirate (15) and cultured as described below.
Cells that grew out from cultured trabecular bone chips
were further expanded in BM with a medium change
every 2–3 days until they reached 90% confluence. Cells
were then removed from the culture plates with 0.25%
trypsin-EDTA, rinsed with PBS, and induced to differ-
entiate into osteoblasts, adipocytes, and chondrocytes as
described previously (21).
Preparation of trabecular bone chips for
histological analysis
Fixed trabecular bone chips were decalcified with
14.3% ethylenediamine tetraacetic acid (EDTA) in wa-




ter for 14 days, rinsed with PBS, dehydrated in a graded
series of ethanol, infiltrated with xylene, and embedded
in paraffin. Histological sections were prepared at 9-m
thickness.
Immunofluorescence analysis
Before staining, paraffin sections were rehydrated and
digested with Digest-All™ 3 pepsin solution for 10 min
at 37°C (Zymed, S. San Francisco, CA). To identify var-
ious cell types in the trabecular bone, sections were
blocked with 1% bovine serum albumin (BSA) in PBS
for 30 min at room temperature, rinsed with PBS, incu-
bated with 1 g/ml of primary antibody (Table 1) in PBS
for 1 hr at 37°C, rinsed with PBS, and incubated with 1
g/ml of secondary antibody in PBS for 1 h at 37°C fol-
lowed by several rinses in PBS. Nuclei were counter-
stained with 1 g/ml of 4,6-diamidino-2-phenylindole
dihydrochloride (DAPI) (Molecular Probes, Eugene,
OR). The following secondary antibodies were used:
Alexa Fluor 568-conjugated goat anti-mouse im-
munoglobulin M (IgM) (A-21043), Alexa Fluor 488-con-
jugated donkey anti-rabbit IgG (A-21206), Alexa Fluor
488-conjugated goat anti-mouse IgG (A11029) (Molec-
ular Probes, Eugene, OR), and fluorescein isothiocyanate
(FITC)-conjugated anti-goat IgG (F2016, Sigma-Aldrich,
St. Louis, MO). Slides were mounted with VEC-
TASHIELD (Vector Laboratories, Inc., Burlingame, CA)
and kept at 20°C in dark until analysis. Sections were
also double stained for Stro-1 and one of several other
differentiated cell markers. To detect 5-bromo-2-de-
oxyuridine (BrdU)-labeled, proliferative cells (see be-
low), sections were stained with biotin-labeled mouse
anti-BrdU antibody (Zymed, S. San Francisco, CA), fol-
lowed by Alexa Fluor 568-conjugated streptavidin (Mo-
lecular Probes, Eugene, OR). To quantify the number of
total cells and cells expressing specific antigens, a min-
imum of 200 DAPI-stained cells were counted per sam-
ple, and data were averaged from triplicate samples from
three separate experiments. Statistical analysis was per-
formed using paired Student’s t-test at a significance level
of p  0.05.
Preparation of trabecular bone-derived cells 
for immunostaining
To identify the various cell types present in the out-
growth monolayer cell culture, bone chips were removed
from day-14 cultures, and the monolayer cells were fixed
with 4% paraformaldehyde, and then stained with the var-
ious markers as described above.
Labeling of proliferative cells
To identify proliferative cells, bone chips were cul-
tured in the presence of BrdU (1:100 dilution in BM)
(Zymed, S. San Francisco, CA) for 24 h at days 1, 3, 7,
14, or 21, respectively. Bone chips were then prepared
for immunohistochemistry as described above.
Light and fluorescence microscopy
Samples were observed with phase-contrast or epiflu-
orescence optics using an Axiovert S100 TV microscope
(Carl Zeiss Microimaging, Inc., Thornwood, NY). Fluo-
rescence images were captured with a SENSYS CCD
camera using IPLab software (Scanalytics, Inc, Fairfax,
VA). All images were processed using Adobe Photoshop
6.0 (Adobe Systems, Inc., San Jose, CA).
RESULTS
Postnatal trabecular bone retains 
multipotential MSCs
Trabecular bone chips isolated from the femoral heads
appeared uniform in size (100 m in diameter) (Fig.
1A, a) and stripped of any surface-associated fibrous tis-
sues or cells as a result of extensive collagenase diges-
TABLE 1. MARKERS FOR DETECTION OF MSCS AND DIFFERENTIATED CELLS IN TRABECULAR BONE
Cell type Marker Antibody used
Mesenchymal stem cells Stro-1 (1,34) STRO-11
Osteoblasts PEBP2- (35) sc-206932
Osteopontin (OPN) (36) sc-105912
Osteoclasts RANK (37) sc-90722
Pericytes -smooth muscle actin (38,39) IMMH23
Endothelial cells Flk-1 (40) sc-50402
von Willebrand’s factor (VWF) (41) sc-140142
Sources: 1Developmental Studies Hybridoma Bank (The University of Iowa, IA); 2Santa Cruz Biotechnology, Inc. (Santa Cruz,
CA); 3Sigma-Aldrich (St. Louis, MO).
tion. Cells became visible after an average of 14 days of
in vitro culturing (Fig. 1A, b). Similar to MSCs derived
from bone marrow (Fig. 1A, c), cells derived from tra-
becular bone chips appeared fibroblastic in shape and
showed extensive cell proliferation potential in vitro. In
addition, as reported previously (4,5,7), these cells were
capable of differentiating into several cell types of mes-
enchymal origin, such as osteoblasts, adipocytes, and
chondrocytes, in response to various inducing factors
(Fig. 1B), a typical characteristic of MSCs.
MSCs migrate out of trabecular bone prior 
to proliferation
To characterize the process by which cells contained
within the trabecular bone chips gave rise to multipo-
tential MSCs, we analyzed their migration and out-
growth from the trabecular bone chips. The number of
cells located within the bone lacunae and those at the
periphery were determined during a 21-day culture pe-
riod. We found that initially the majority of DAPI-
stained cells (86.8%) were located inside the lacunae of
freshly isolated trabecular bone chips, and only a small
percentage of cells (13.2%) were found associated with
the periphery of the bone chips. The percentage of cells
in the lacunae gradually decreased over time, as only
13% of total cells were retained inside the bone chips
by day 21 (Fig. 2B). At the same time, the amount of
DAPI-stained cells appearing at the periphery of the
bone chips increased from 13.2% on day 0 to 87% on
day 21.
To determine whether the cells residing in the trabec-
ular bone could proliferate, BrdU was included in the cul-
ture medium to label proliferating cells. No cell prolifer-
ation was detected inside the trabecular bone, because
none of the cells located in the lacunae incorporated
BrdU. Cells that incorporated BrdU were found exclu-
sively at the periphery of the bone chips or outside the
chips altogether (Fig. 2A, i), suggesting that cells only
proliferated after having migrated out of the bone struc-
ture, and that cell proliferation was likely inhibited in-
side the trabecular bone. To examine the relationship be-
tween cell proliferation and cell outgrowth, trabecular
bone chips were cultured in the presence of the cell cy-
cle inhibitor, aphidicolin. Interestingly, cells still mi-
grated out of the trabecular bone in the absence of cell
division. As expected, without aphidicolin treatment, a
dramatically higher number of cells was observed out-
side the bone chips, likely due to extensive cell prolifer-
ation over the 5-week culture period. However, there was
no significant difference in the number of cells retained
in the bony lacunae, with or without aphidicolin treat-
ment (Fig. 3). Approximately 10% of cells were detected
in the lacunae in the presence of the inhibitor, whereas
6.5% were retained in the absence of aphidicolin after 5
weeks. Taken together, these results suggest that migra-
tion or outgrowth of trabecular bone cells is independent
of cell proliferation.
MSCs represent a rare cell population in
trabecular bone
Cells derived from trabecular bone chips possessed ex-
tensive proliferative ability and multilineage differentia-
tion potential, similar to MSCs derived from bone mar-
row (4,5,7). To determine the location of these MSCs in
trabecular bone, freshly isolated trabecular bone chips
were immunostained for markers characteristic of vari-
ous cell types, including MSCs, osteoblasts, osteoclasts,
endothelial cells, and pericytes (see Table 1). The tra-
becular bone chips did not contain pericytes as no cells
were found to express -smooth muscle actin. As shown
in Fig. 4, the bone chips contained cells positive for
STRO-1, PEBP2-, RANK, Flk-1, and VWF antibodies
(Table 2), suggesting the presence of MSCs, osteoblasts,
osteoclasts, and endothelial cells, respectively. Surpris-
ingly, the total percentage of cells that were positive for
these five markers was in excess of 100% (Fig. 5A), sug-
gesting the existence of cells that expressed more than
one cell type marker. To characterize the MSCs present
in trabecular bone further and to distinguish them from
other cell types, cells were co-stained with Stro-1 anti-
body in combination with another antibody of the dif-
ferentiated cell markers. As shown in Fig. 5B, the ma-
jority of Stro-1-positive cells (which made up
approximately 9.4% of total cells) did express other
markers: 5% for PEBP2-, 22% for RANK, 27% for Flk-
1, and 22% for VWF. However, the remainder (approx-
imately 2.2% of total trabecular cells) was positive only
for Stro-1, indicating the existence of true MSCs in adult
trabecular bone.
Stro-1-positive trabecular bone cells give rise to
multipotent stem and progenitor cells
To identify which trabecular bone cell type migrated
out and subsequently gave rise to the multipotent MSC
population, trabecular bone chips were cultured for 14
days in vitro. More than 50% of the cells migrated out
of the bone chips. Cells that remained in the bony lacu-
nae and cells that migrated out and gave rise to the mono-
layer outside of the bone chips were immunostained.
Compared to freshly isolated trabecular bone chips, Stro-
1-positive cells were not detected within the bone chips
after 14 days of culture (Table 2). The percentage of cells
positive for differentiated cell markers also decreased
slightly (Table 2), suggesting that some of these cells had
also migrated out of the bone chips. On the other hand,
47% of the monolayer cell population outside of the bone
chips was Stro-1 positive, a five-fold increase in abun-
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dance compared to that inside the bone chips (Table 2),
suggesting that they migrated out of the bone chips. Un-
expectedly, almost all of these Stro-1-positive cells co-
expressed PEBP2-, RANK, Flk-1, and VWF (Table 2).
This finding is consistent with our earlier observation of
the presence of similar, co-stained cells inside the tra-
becular bone chips. Taken together, these results suggest
that Stro-1-positive trabecular bone cells are likely to be
the cell source that gives rise to the multipotent stem and
progenitor cells.
DISCUSSION
The existence of adult stem cells in connective tissues
has been under debate, owing to the lack of both unique
cell markers and valid in vivo functional analysis, such
as the transplantation and rescue assay widely used to
confirm the existence of HSCs (as reviewed in ref. 22).
However, numerous studies have demonstrated the exis-
tence of multipotential stem and progenitor cells in var-
ious adult tissues, on the basis of their capability for ex-
tensive self-renewal and multilineage differentiation in
vitro. However, it is difficult to identify the location of
these stem cells in vivo, and/or to elucidate how they mi-
grate to the tissue remodeling and injury site from their
native microenvironment.
In this study, we have postulated that one type of con-
nective stem cells, MSCs, exist in postnatal trabecular
bone, and that bone could be used as a model to study
the migration and homing process of adult stem cells.
Several lines of evidence support our hypothesis. First of
all, cells derived from trabecular bone exhibit two fun-
damental characteristics of MSCs. First, they show ex-
tensive proliferation as well as the ability to differentiate
into multiple cell types (4–6), consistent with their being
stem or progenitor cells. Second, no cell proliferation oc-
curs inside the trabecular bone, similar to observations
made on the germ cell niche in Drosophila reproductive
systems (23–26), and in the hematopoietic stem cell
(HSC) niche in murine bone marrow (9,10). For exam-
ple, HSCs are maintained in a very slow cycling state by
the neighboring osteoblasts through Notch/Jagged1 and
N-cadherin-mediated cell interactions in their niche at the
endosteal surface of long bones (as reviewed in ref. 27).
Once HSCs detach from the osteoblastic niche, either by
matrix metalloproteinase activity or via asymmetric cell
division, they begin to proliferate and replenish the he-
matopoietic cell populations. Similarly, MSCs stay in a
mitotically quiescent state until they have migrated out
of the trabecular bone. Therefore, this observation
strongly suggests that trabecular bone functions as one
of the MSC niches.
Using immunostaining, we have demonstrated the ex-
istence of multiple cell types in adult trabecular bone, in-
cluding cells with the characteristics of osteoblasts, os-
teoclasts, endothelial cells, and MSCs. We did not detect
any pericytes in trabecular bone, although they have been
suggested as candidate cells to give rise to multipotential
MSCs and progenitor cells in various connective tissues
(28–30). Our results show that pericytes are not the ma-
jor cell type contributing to the multipotent MSCs. On
the other hand, our study does not exclude the possibil-
ity that pericytes may contribute to the generation of pro-
genitor cells in other, nontrabecular bone sources, such
as umbilical cord blood (31). Surprisingly, we did not
identify any cells positive for OPN, a marker for mature
osteoblasts. Because osteoblasts are usually found lining
the bone surface, they may have been excluded from the
trabecular bone chips used here, which have been pre-
pared by extensive enzymatic digestion. A portion of
Stro-1-positive cells in the trabecular bone chips express
markers of other differentiated cells, implying the meso-
dermal origin of these cells. Compared to the low abun-
dance of MSCs in bone marrow (32,33), umbilical cord
blood (31), and adipose tissue (18), adult trabecular bone
is a relatively rich source for MSCs, because they com-
prise 2.2% of the total cell population. The close prox-
imity of these cells to bone marrow implies that trabec-
ular bone might function as a reservoir to supply MSCs
to bone marrow, before the cells circulate to the tissue
injury sites for regeneration and repair.
Interestingly, Stro-1-positive cells are no longer de-
tected inside the trabecular bone chips after 14 days of
culture. On the other hand, close to half of the monolayer
cell population outside of the trabecular bone chips are
positive for Stro-1, indicating that these cells are derived
from the Stro-1-expressing trabecular bone cells, thereby
contributing to the generation of multipotential MSCs.
FIG. 3. Percentage of cells retained in trabecular bone after
5 weeks of in vitro culturing in the presence or absence of the
cell proliferation inhibitor aphidicolin. No statistical difference
was seen, suggesting that cell proliferation was not essential to
cell migration and outgrowth.
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FIG. 4. Existence of multiple cell types, including Stro-1-positive mesenchymal stem cells, in trabecular bone as detected by im-
munofluorescence. (Left panels) Phase-contrast micrographs showing trabecular bone sections. (Middle panels) Epifluorescence mi-
crographs showing DAPI-stained cells. (Right panels) Epifluorescence micrographs showing antibody-stained cells. (a–c) Stro-1; (d–f)
PEBP2-; (g–i) RANK; (j–l) VWF; (m–o) Flk-1; (p–r), OPN; (s–u), -smooth muscle actin. Scale bar, 50 m.
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This could also explain why, in a previous study, only
11 out of 23 colonies of cells (i.e., 48%) derived from
trabecular bone are able to differentiate into all three mes-
enchymal lineages (6). Unexpectedly, almost all of the
Stro-1-positive cells in monolayer are found to co-ex-
press other differentiated cell markers, whereas a distinct
population (2.2%) of the cells located initially within the
trabecular bone are exclusively positive for Stro-1. What
was the fate of these exclusively Stro-1-positive cells dur-
ing in vitro culture? They could have been diluted in the
monolayer cell population as a result of their relatively
slower proliferation rate than others, thus making their
detection difficult if not impossible. Stro-1-positive cells
from the trabecular bone could also have acquired dif-
ferentiated cell markers during the course of in vitro cul-
ture, possibly as a result of induction by various growth
factors present in the serum. These cells appear to retain
an undifferentiated state, because they lack the pheno-
typic and functional characteristics of differentiated cells.
Nonetheless, Stro-1-positive cells appear to be the major
cell type that proliferate and populate the monolayer cell
culture, regardless of whether they express other mark-
ers. Therefore, as suggested by our previous study (5),
we postulate that Stro-1-expressing MSCs play a key role
in replenishing the stem cell pool as well as in generat-
ing differentiated cells. Because committed cells could
also dedifferentiate and regain their multipotentiality
(21), cells that coexpress the stem cell marker Stro-1 and
markers of other differentiated cells could thus function
as an alternative source for MSCs in vivo, which may
count for the functional heterogeneity of clonal cells ob-
served in vitro (6).
What signals trigger the migration of MSCs from the
trabecular bone niche in vitro? Do the same signals play
a key role in vivo during tissue homeostasis and damage
repair? By blocking cellular division with a cell cycle in-
hibitor, we have demonstrated that cell migration is in-
dependent of cell proliferation, thus excluding the possi-
bility that proliferation is a prerequisite for cell migration
and outgrowth. In vitro, trabecular bone is cultured in a
serum-supplemented medium, enriched with multiple
growth factors and signaling molecules. The extended pe-
riod of culturing also could deplete the endogenous fac-
TABLE 2. RELATIVE ABUNDANCE OF TRABECULAR BONE-DERIVED CELLS
POSITIVE FOR STEM AND DIFFERENTIATED CELL MARKERS
Percent of positive cells (average  SD)
Within lacunae Within lacunae In monolayer
Marker (day 0) (day 14) (day 14)
Stro-1 9.4  5.00 0 47.1  5.0
PEBP2- 31.9  10.4 27.9  14.9 65.3  0.2
RANK 38.4  5.40 27.9  13.1 43.2  1.3
Flk-1 36.7  26.6 16.4  11.8 87.0  2.3
VWF 32.8  8.80 11.7  4.70 76.4  2.9
OPN N.D. N.D. N.D.
-actin N.D. N.D. N.D.
N.D., Not detected.
FIG. 5. Abundance of cells expressing various cell markers
(A) and co-expressing Stro-1 and other differentiated cell mark-
ers (B) in trabecular bone. These results demonstrated the pres-
ence of osteoblastic, osteoclastic, and endothelial cells, as well
as MSC-like cells in the trabecular bone chips. No pericytes or
smooth muscle cells were found. Although most of the Stro-1-
positive cells co-expressed differentiated cell markers, 2.2%
was exclusively Stro-1 positive.
tors normally sequestered in the extracellular matrix. The
combined effects of the gradual loss of endogenous in-
hibitors of cell proliferation from the matrix and the pres-
ence of stimulatory growth factors in the culture medium
would result in promotion of the outgrowth of cells from
the trabecular bone chips and support subsequent cell pro-
liferation. The fact that outgrowing cells only become
visible after an extended culture period supports this the-
ory. In addition, we postulate that similar events are very
likely to be involved in stem cell-mediated skeletal tis-
sue regeneration in vivo, because the process of bone
fracture and damage mimics the dissociative steps used
here to prepare trabecular bone chips, whereas subse-
quent cultivation mimics the tissue repair process. How-
ever, the identities and mechanisms of action of extrin-
sic (from the regulatory niche) and intrinsic (inside the
stem cells) factors controlling the renewal and mainte-
nance of MSC in trabecular bone remain to be investi-
gated.
In summary, our study demonstrates the existence of
multipotential stem cells in adult connective tissues and, for
the first time, provides useful insights into the behavior and
function of stem cells during tissue homeostasis and repair.
In vitro culturing of adult trabecular bone chips presents
great potential as a useful system to identify extrinsic fac-
tors as well as the intrinsic signaling pathways that stimu-
late stem cell migration and subsequent proliferation and
differentiation in response to tissue injury. Identification
and characterization of these factors should enhance our
understanding of the fundamental developmental processes
and also provide cellular targets for potential pharmaco-
logical reagents that would accelerate the fracture healing
and bone regeneration processes.
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